Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes

Piero Ruggenenti; Ilian Iliev; Grazia Maria Costa; Aneliya Parvanova; Annalisa Perna; Giovanni Giuliano; Nicola Motterlini; Bogdan Ene‐Iordache; Giuseppe Remuzzi

doi:10.2337/dc08-0371

Back

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes

Article 2008 en

Abstract

1 min read

ACE inhibition has a specific protective effect against the development of ECG-LVH that is additional to its blood pressure-lowering effect. Because ECG-LVH is a strong cardiovascular risk factor in people with hypertension and diabetes, early ACE inhibition may be cardioprotective in this population.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

Optimal Threshold Value for Left Ventricular Hypertrophy in Blacks

Eduardo Núñez, Donna K. Arnett, Emelia Benjamin, Philip R. Liebson, Thomas N. Skelton, Herman Taylor, Michael E. Andrew

Article2006

Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes

Giuseppe Remuzzi, Manuel Macı́a, Piero Ruggenenti

Article2023

Community echocardiographic left ventricular hypertrophy and mortality in South Asians in the UK: E-ECHOES study

Eduard Shantsila, Alena Shantsila, Nefyn Williams, Professor Gregory Lip, Paramjit Gill

Article2011

Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Article2012

Circadian Pattern of Ambulatory Blood Pressure in Hypertensive Patients With and Without Type 2 Diabetes

Diana E. Ayala, Ana Moyá, Juan J. Crespo, Carmen Castiñeira, Manuel Domínguez-Sardiña, Sonia M. Gomara, Elvira Sineiro, Artemio Mojón, M. J. Fontao, Ramon C Hermida